DK136651C - - Google Patents

Info

Publication number
DK136651C
DK136651C DK55574A DK55574A DK136651C DK 136651 C DK136651 C DK 136651C DK 55574 A DK55574 A DK 55574A DK 55574 A DK55574 A DK 55574A DK 136651 C DK136651 C DK 136651C
Authority
DK
Denmark
Application number
DK55574A
Other languages
Danish (da)
Other versions
DK136651B (da
Inventor
A R J Castaigne
Original Assignee
Centre D'etudes Pour L'industrie Pharmaceutique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre D'etudes Pour L'industrie Pharmaceutique filed Critical Centre D'etudes Pour L'industrie Pharmaceutique
Priority to DK466376A priority Critical patent/DK141703B/da
Publication of DK136651B publication Critical patent/DK136651B/da
Application granted granted Critical
Publication of DK136651C publication Critical patent/DK136651C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK55574AA 1973-02-01 1974-02-01 Analogifremgangsmåde til fremstilling af pyridinderivater, deres syreadditionssalte eller deres kvaternære ammoniumforbindelser. DK136651B (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK466376A DK141703B (da) 1973-02-01 1976-10-15 Analogifremgangsmåde til fremstilling af pyridiniumderivater.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7303503A FR2215948B1 (cg-RX-API-DMAC10.html) 1973-02-01 1973-02-01

Publications (2)

Publication Number Publication Date
DK136651B DK136651B (da) 1977-11-07
DK136651C true DK136651C (cg-RX-API-DMAC10.html) 1978-04-17

Family

ID=9114160

Family Applications (1)

Application Number Title Priority Date Filing Date
DK55574AA DK136651B (da) 1973-02-01 1974-02-01 Analogifremgangsmåde til fremstilling af pyridinderivater, deres syreadditionssalte eller deres kvaternære ammoniumforbindelser.

Country Status (16)

Country Link
US (1) US4051141A (cg-RX-API-DMAC10.html)
JP (1) JPS5231357B2 (cg-RX-API-DMAC10.html)
AT (1) AT338261B (cg-RX-API-DMAC10.html)
AU (1) AU473141B2 (cg-RX-API-DMAC10.html)
BE (1) BE809812A (cg-RX-API-DMAC10.html)
CA (1) CA1038871A (cg-RX-API-DMAC10.html)
CH (1) CH593287A5 (cg-RX-API-DMAC10.html)
DK (1) DK136651B (cg-RX-API-DMAC10.html)
ES (2) ES422581A1 (cg-RX-API-DMAC10.html)
FR (1) FR2215948B1 (cg-RX-API-DMAC10.html)
GB (1) GB1445524A (cg-RX-API-DMAC10.html)
IL (3) IL49786A (cg-RX-API-DMAC10.html)
NL (1) NL7401237A (cg-RX-API-DMAC10.html)
PH (2) PH11451A (cg-RX-API-DMAC10.html)
SE (2) SE416203B (cg-RX-API-DMAC10.html)
ZA (1) ZA74488B (cg-RX-API-DMAC10.html)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2345150A2 (fr) * 1975-08-06 1977-10-21 Centre Etd Ind Pharma Nouveaux derives de la thienopyridine, et leur application
FR2313055A2 (fr) * 1975-06-05 1976-12-31 Parcor Nouveaux derives substitues de la thieno-pyridine, leur procede de preparation et leurs applications
FR2312246A1 (fr) * 1975-05-28 1976-12-24 Parcor Derives de la tetrahydro-4,5,6,7 thieno (3,2-c) pyridine, leur procede de preparation et leurs applications
FR2312247A1 (fr) * 1975-05-30 1976-12-24 Parcor Derives de la thieno-pyridine, leur procede de preparation et leurs applications
FR2315274A1 (fr) * 1975-06-27 1977-01-21 Parcor Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications
US4163852A (en) * 1975-07-09 1979-08-07 Parcor Process for the preparation of tetrahydro-thieno[3,2-c]- and [2,3-c]pyridine derivatives
JPS5283950A (en) * 1976-01-02 1977-07-13 Sentore Deechiyuude Puuru Rand Medicine for disease derived from blood magma
FR2338703A1 (fr) * 1976-01-22 1977-08-19 Parcor Derives de thieno (3,2-c) pyridine, leur procede de preparation et leurs applications
FR2376860A1 (fr) * 1977-01-07 1978-08-04 Parcor Tetrahydro-4,5,6,7 thieno (2,3-c) et (3,2-c) pyridines, leur procede de preparation et leur application therapeutique
GB2038625B (en) * 1978-12-29 1983-01-12 Parcor Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
FR2395028A2 (fr) * 1977-06-22 1979-01-19 Centre Etd Ind Pharma Derives pyridiniques, leur preparation et leurs application therapeutique
GB2038178B (en) * 1978-12-29 1983-03-09 Parcor Antithrombotic therapeutic compsition
US4464377A (en) * 1977-06-22 1984-08-07 BLANCHARD Jean Anti-thrombotic therapeutic compositions
FR2397417A1 (fr) * 1977-07-12 1979-02-09 Parcor Procede de preparation de derives de la thienopyridine
JPS5498337A (en) * 1978-01-06 1979-08-03 Dai Ichi Seiyaku Co Ltd Anticarcinogenic and/or antimetastatic agent
JPS54105236A (en) * 1978-02-06 1979-08-18 Dai Ichi Seiyaku Co Ltd Antithrombogenetic agent for shunt and/or artificial blood vessel
FR2426046A1 (fr) 1978-05-18 1979-12-14 Synthelabo Derive de tetrahydro-isoquinoleine, sa preparation et son application en therapeutique
US4490377A (en) * 1980-07-29 1984-12-25 Syntex (U.S.A.) Inc. Acid stabilized compositions of thieno-pyridine derived compounds
US4400384A (en) * 1980-10-06 1983-08-23 Sanofi, S.A. 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-c] pyridine methanesulfonate and other novel salts thereof
US4321266A (en) * 1980-10-06 1982-03-23 Sanofi 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-C] pyridine
FR2495156A1 (fr) * 1980-11-28 1982-06-04 Sanofi Sa Derives de la thieno-pyridinone, leur procede de preparation et leur application therapeutique
FR2495157A1 (fr) * 1980-11-28 1982-06-04 Sanofi Sa Procede nouveau de preparation des tetrahydro-5, 6, 7, 7a 4h-thieno (3, 2-c) pyridinones-2
FR2495158A1 (fr) * 1980-11-28 1982-06-04 Sanofi Sa Nouveau procede de preparation de derives de la tetrahydro-5, 6, 7, 7a 4h-thieno (3, 2-c) pyridinone-2
FR2508442A1 (fr) * 1981-06-30 1982-12-31 Sanofi Sa Procede de preparation d'ethylamines b-cyclo-substituees et produits ainsi obtenus
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
IT8222600A0 (it) * 1982-07-28 1982-07-28 Pietro Tommaso Tessitore Nuovi idrossibenzensolfonati della 5-(o-clorobenzil)-4,5,6,7-tetraidro tieno parentesi quadra aperta 3,2-c parentesi quadra chiusa piridina.
JPS6044344U (ja) * 1983-09-03 1985-03-28 オムロン株式会社 リレ−の駆動回路
FR2566775B1 (fr) * 1984-06-27 1986-10-31 Synthelabo Derives de tetrahydro-4,5,6,7 furo ou 1h-pyrrolo(2,3-c)pyridine, leur preparation et leur application en therapeutique
FR2570701B1 (fr) * 1984-09-27 1987-05-22 Synthelabo Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
JPS6185391A (ja) * 1984-10-03 1986-04-30 Nisshin Flour Milling Co Ltd ５−（２−クロロベンジル）−４，５，６，７−テトラヒドロチエノ〔３，２−ｃ〕ピリジンの製造方法
GB8429087D0 (en) * 1984-11-16 1984-12-27 Scras Thienopyridine derivatives
FR2612777A1 (fr) * 1987-03-26 1988-09-30 Inst Nat Sante Rech Med Composition medicamenteuse pour le traitement et la prevention de maladies dues a une cytotoxicite a mediation cellulaire, renfermant au moins un derive de la pyridine comme principe actif
US4906756A (en) * 1988-05-10 1990-03-06 Syntex (U.S.A.) Inc. 2-(2-nitrovinyl)thiophene reduction and synthesis of thieno[3,2-c]pyridine derivatives
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5053393A (en) * 1988-07-20 1991-10-01 Monsanto Company Novel platelet-aggregation inhibitor
US4992463A (en) * 1988-07-20 1991-02-12 Monsanto Company Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation
US5037808A (en) * 1988-07-20 1991-08-06 Monsanto Co. Indolyl platelet-aggregation inhibitors
JPH02145581A (ja) * 1988-10-11 1990-06-05 Lonza Ag 置換チエニルエチルアミンとその製造方法
GB8824400D0 (en) * 1988-10-18 1988-11-23 Glaxo Group Ltd Chemical compounds
US4997945A (en) * 1990-01-25 1991-03-05 Syntex (U.S.A.) Inc. Carbamate salts of 2-(2'-thienyl)alkylamines
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
CA2087743C (en) * 1992-02-06 1999-04-27 Akio Odawara Pharmaceutical composition for inhibiting platelet aggregation
US5296603A (en) * 1992-06-08 1994-03-22 Fuji Photo Film Co., Ltd. 3-amino-5-o-chlorobenzyl-4,5,6,7-tetrahydrothieno[3,2-c]-pyridine-2-carboxylic acid compounds
US5294621A (en) * 1992-10-07 1994-03-15 Ortho Pharmaceutical Corporation Thieno tetrahydropyridines useful as class III antiarrhythmic agents
NZ334389A (en) * 1996-08-28 2001-05-25 Ube Industries Cyclic amine derivatives
US6043368A (en) * 1996-09-04 2000-03-28 Poli Industria Chimica, S.P.A. Method of making thieno-pyridine derivatives
US5872128A (en) * 1997-10-15 1999-02-16 Invamed, Inc. Stabilized composition of ticlopidine hydrochloride
BRPI9908319B8 (pt) 1998-02-27 2021-07-06 Sankyo Co composto amino cíclico, composição farmacêutica, medicamento contendo um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo, e, uso de um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo.
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
US20090297597A1 (en) * 1998-11-02 2009-12-03 Gary Liversidge Modified Release Ticlopidine Compositions
AU3192700A (en) 1999-03-17 2000-10-04 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
MXPA03005770A (es) 2000-12-25 2003-09-10 Sankyo Co Composiciones medicinales que contienen aspirina.
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US20050192245A1 (en) * 2002-07-18 2005-09-01 Sankyo Company, Limited Medicinal composition for treating arteriosclerosis
CA2454015C (en) * 2003-12-23 2009-11-24 Brantford Chemicals Inc. A process for the preparation of tetrahydrothieno [3,2-c] pyridine derivatives
EP1901718A4 (en) * 2005-06-13 2012-07-18 Elan Pharma Int Ltd TICLOPIDINE COMPOSITIONS WITH MODIFIED RELEASE
US20100062066A1 (en) * 2006-11-14 2010-03-11 Acusphere, Inc Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
US20100297621A1 (en) * 2007-06-20 2010-11-25 University Of Utah Research Foundation Use of pre-mrna splicing in platelet cells for the diagnosis of disease
CN102241690B (zh) * 2010-05-13 2015-08-12 天津药物研究院 一类含腈基的噻吩并吡啶酯类衍生物、其制备方法和用途
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide

Also Published As

Publication number Publication date
AU6501074A (en) 1975-07-31
JPS5231357B2 (cg-RX-API-DMAC10.html) 1977-08-13
DE2404308B2 (de) 1977-06-30
AT338261B (de) 1977-08-10
CH593287A5 (cg-RX-API-DMAC10.html) 1977-11-30
ZA74488B (en) 1974-11-27
ES445702A1 (es) 1977-06-01
ES422581A1 (es) 1976-10-01
CA1038871A (en) 1978-09-19
PH11759A (en) 1978-06-27
DE2404308A1 (de) 1974-08-08
SE7703028L (sv) 1977-03-17
PH11451A (en) 1978-02-01
AU473141B2 (en) 1976-06-17
FR2215948B1 (cg-RX-API-DMAC10.html) 1976-05-14
FR2215948A1 (cg-RX-API-DMAC10.html) 1974-08-30
NL7401237A (cg-RX-API-DMAC10.html) 1974-08-05
ATA67874A (de) 1976-12-15
IL49786A0 (en) 1976-08-31
GB1445524A (en) 1976-08-11
SE421624B (sv) 1982-01-18
DK136651B (da) 1977-11-07
IL49786A (en) 1977-06-30
US4051141A (en) 1977-09-27
BE809812A (fr) 1974-07-16
JPS5046688A (cg-RX-API-DMAC10.html) 1975-04-25
IL44061A0 (en) 1974-05-16
SE416203B (sv) 1980-12-08
IL44061A (en) 1977-06-30

Similar Documents

Publication Publication Date Title
AR201758A1 (cg-RX-API-DMAC10.html)
AU476761B2 (cg-RX-API-DMAC10.html)
AU465372B2 (cg-RX-API-DMAC10.html)
AR201235Q (cg-RX-API-DMAC10.html)
AR201231Q (cg-RX-API-DMAC10.html)
JPS5046688A (cg-RX-API-DMAC10.html)
AU474593B2 (cg-RX-API-DMAC10.html)
AU474511B2 (cg-RX-API-DMAC10.html)
AU474838B2 (cg-RX-API-DMAC10.html)
AU471343B2 (cg-RX-API-DMAC10.html)
AU465453B2 (cg-RX-API-DMAC10.html)
AU465434B2 (cg-RX-API-DMAC10.html)
AU450229B2 (cg-RX-API-DMAC10.html)
AU476714B2 (cg-RX-API-DMAC10.html)
AR201229Q (cg-RX-API-DMAC10.html)
AU466283B2 (cg-RX-API-DMAC10.html)
AR199451A1 (cg-RX-API-DMAC10.html)
AU476696B2 (cg-RX-API-DMAC10.html)
AU472848B2 (cg-RX-API-DMAC10.html)
AU477823B2 (cg-RX-API-DMAC10.html)
AU477824B2 (cg-RX-API-DMAC10.html)
AR200885A1 (cg-RX-API-DMAC10.html)
AR200256A1 (cg-RX-API-DMAC10.html)
AR195311A1 (cg-RX-API-DMAC10.html)
AR195948A1 (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
PUP Patent expired